Our Services
Medical Information
Helpful Resources
Published on: 6/17/2026
Blood in the urine, known as hematuria, is the most common early sign of bladder cancer. It may appear as pink, red, or cola-colored urine, or it might only be detectable under a microscope during a urinalysis. While hematuria can stem from less serious causes like urinary tract infections or kidney stones, it should never be ignored.
Several factors—including age, smoking history, chemical exposure, and recurrent urinary symptoms—can influence diagnosis, treatment options, and follow-up care. Understanding these variables is essential to guiding your next steps.
Because early detection dramatically improves bladder cancer outcomes, it's worth taking a few minutes to evaluate your symptoms now. A free, instant, online symptom check can help you identify possible causes, understand the urgency of your situation, and decide whether to see a doctor—empowering you with clarity before your next appointment.
Reviewed for medical accuracy: 06/17/2026
Bladder cancer is a common but often treatable disease when detected early. While there are various warning signs, the first symptom doctors notice most often is blood in the urine, also known as hematuria. Recognizing this early sign can lead to faster diagnosis and better outcomes.
When patients first visit their doctor for bladder cancer concerns, the majority report seeing blood in their urine. This can appear as pink, red, or cola-colored urine, and it may be:
Even if you only notice blood once, it's important not to ignore it. Hematuria doesn't always hurt or cause other symptoms, but it still warrants prompt evaluation.
Blood in the urine can happen for several reasons related to bladder cancer:
While hematuria is the most common first sign, bladder cancer can sometimes present with other early symptoms.
Although less common than hematuria, additional symptoms may include:
These symptoms can overlap with other, less serious conditions (like bladder infections or kidney stones), so a proper work-up is essential.
Certain factors raise the likelihood of developing bladder cancer. If you have one or more of these, be especially vigilant:
Even without these risk factors, anyone can develop bladder cancer. Early detection remains key.
When you report hematuria or other warning signs, your doctor may suggest:
Urine tests
Imaging studies
Cystoscopy
Biopsy and pathology
Each step helps your doctor understand the stage (extent) and grade (aggressiveness) of the cancer, guiding the best treatment plan.
Treatment for bladder cancer depends on the stage, grade, and overall health. Common approaches include:
Transurethral resection of bladder tumor (TURBT)
Intravesical therapy
Radical cystectomy
Chemotherapy and radiation
Immunotherapy
Your medical team will tailor a plan based on your specific situation, balancing effectiveness with quality of life.
Even after successful initial treatment, bladder cancer can recur. Follow-up typically involves:
Adherence to follow-up schedules greatly improves long-term outcomes.
If you notice any of the warning signs below, don't delay talking to a healthcare professional:
If you're experiencing urinary symptoms and want to better understand what they might mean before your doctor's appointment, try Ubie's free AI-powered Bladder Cancer / Ureteric Cancer / Renal Pelvis Cancer symptom checker to assess your symptoms and learn about potential next steps.
While not all cases can be prevented, you can lower your risk by:
The first sign doctors see most often in bladder cancer is blood in the urine. Early detection, accurate diagnosis, and timely treatment are crucial for the best possible outcome. If you experience any concerning urinary changes, speak with your doctor right away.
This information is not a substitute for professional medical advice. Always consult a healthcare provider if you have any symptoms that could be life-threatening or serious.
(References)
* Babjuk M, Burger M, Capoun O, et al. EAU Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and CIS). Eur Urol. 2022 Apr;81(4):379-390. doi: 10.1016/j.eururo.2022.01.006. Epub 2022 Feb 25. PMID: 35227702.
* Chang SS, Boorjian SA, Chou R, et al. AUA Guidelines for the Diagnosis and Treatment of Nonmuscle Invasive Bladder Cancer: An Update. J Urol. 2020 May;203(5):877-884. doi: 10.1097/JU.0000000000000780. Epub 2020 Feb 28. PMID: 32200473.
* Witjes JA, Bruins HM, van der Heijden AG, et al. Diagnosis and management of non-muscle invasive bladder cancer. Eur Urol Focus. 2020 Mar 15;6(2):206-218. doi: 10.1016/j.euf.2020.02.001. Epub 2020 Mar 2. PMID: 32204910.
* Babjuk M, Soukup V, Zigeuner R, et al. Current challenges in the diagnosis and treatment of bladder cancer. Urol Oncol. 2020 Nov;38(11):806-817. doi: 10.1016/j.urolonc.2020.06.012. Epub 2020 Jul 17. PMID: 32682662.
* Chang SS, Baumgartner RN, Clark PE, et al. Clinical presentation of bladder cancer: analysis of 1,200 cases. J Urol. 2014 Aug;192(2):397-401. doi: 10.1016/j.juro.2014.04.072. Epub 2014 May 1. PMID: 24792036.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.